SNY Sanofi

FRANKFURT--The following is a summary of analysts' forecasts for Sanofi SA (SNY) fourth-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 9.

=== 
                                Business  Business 
                    Net   Sales    Oper.       Net  Business 
4th Quarter       sales  Lantus   Income    income       EPS 
AVERAGE           9,416   1,621    2,281     1,646      1.26 
Prev. Year        9,072   1,772    2,443     1,828      1.39 
+/- in %           +3.8    -8.5     -6.6       -10      -9.2 
 
MEDIAN            9,478   1,662    2,207     1,596      1.23 
Maximum           9,716   1,745    2,485     1,821      1.40 
Minimum           9,105   1,364    2,173     1,528      1.17 
Amount (a)            7       7        8         8         8 
 
Baader-Helvea     9,614   1,745    2,485     1,821      1.40 
Barclays          9,139   1,586    2,173     1,581      1.21 
Cowen and Company 9,716   1,685    2,481     1,781      1.36 
Deutsche Bank     9,239   1,662    2,193     1,592      1.22 
Jefferies         9,619   1,719    2,214     1,573      1.21 
Morgan Stanley    9,478      --    2,312     1,692      1.30 
UBS               9,105   1,585    2,199     1,599      1.23 
 
 
               Target price  Rating                 DPS 2015 
AVERAGE               87.38  positive 2    AVERAGE      2.94 
Prev. Quarter        102.00  neutral  5    Prev. Year   2.85 
+/- in %                -14  negative 1    +/- in %     +3.2 
 
MEDIAN                85.50                MEDIAN       2.92 
Maximum              100.00                Maximum      3.05 
Minimum               76.00                Minimum      2.85 
Amount                    8                Amount          6 
 
Baader-Helvea         87.00  Hold                         -- 
Barclays              84.00  Equalweight                2.90 
Credit Suisse        100.00  Outperform                 2.85 
Deutsche Bank        100.00  Buy                        3.00 
Exane BNP Paribas     80.00  Underperform               2.94 
Independent Research  82.00  Hold                       2.90 
Jefferies             76.00  Hold                         -- 
UBS                   90.00  Neutral                    3.05 
=== 

Year-earlier figures are as reported by the company.

(a) Including anonymous estimates from one more analyst.

DJG/voi 

(END) Dow Jones Newswires

February 05, 2016 10:02 ET (15:02 GMT)

Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Aug 2024 to Sep 2024

Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Sep 2023 to Sep 2024